201 related articles for article (PubMed ID: 11773382)
1. Protective effect of avian myelomonocytic growth factor in infection with Marek's disease virus.
Djeraba A; Musset E; Lowenthal JW; Boyle DB; Chaussé AM; Péloille M; Quéré P
J Virol; 2002 Feb; 76(3):1062-70. PubMed ID: 11773382
[TBL] [Abstract][Full Text] [Related]
2. Similar pattern of iNOS expression, NO production and cytokine response in genetic and vaccination-acquired resistance to Marek's disease.
Djeraba A; Musset E; Bernardet N; Le Vern Y; Quéré P
Vet Immunol Immunopathol; 2002 Feb; 85(1-2):63-75. PubMed ID: 11867168
[TBL] [Abstract][Full Text] [Related]
3. Antiviral and antitumoral effects of recombinant chicken myelomonocytic growth factor in virally induced lymphoma.
Djeraba A; Kut E; Rasschaert D; Quéré P
Int Immunopharmacol; 2002 Oct; 2(11):1557-66. PubMed ID: 12433057
[TBL] [Abstract][Full Text] [Related]
4. Interferon-γ influences immunity elicited by vaccines against very virulent Marek's disease virus.
Haq K; Elawadli I; Parvizi P; Mallick AI; Behboudi S; Sharif S
Antiviral Res; 2011 Jun; 90(3):218-26. PubMed ID: 21501630
[TBL] [Abstract][Full Text] [Related]
5. Marek's disease virus induces Th-2 activity during cytolytic infection.
Heidari M; Zhang HM; Sharif S
Viral Immunol; 2008 Jun; 21(2):203-14. PubMed ID: 18433333
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling in rMd5- and rMd5deltameq-infected chickens.
Xu M; Zhang H; Lee L; Gao H; Sharif S; Silva RF; Heidari M
Avian Dis; 2011 Sep; 55(3):358-67. PubMed ID: 22017031
[TBL] [Abstract][Full Text] [Related]
7. Influence of genetic resistance of the chicken and virulence of Marek's disease virus (MDV) on nitric oxide responses after MDV infection.
Jarosinski KW; Yunis R; O'Connell PH; Markowski-Grimsrud CJ; Schat KA
Avian Dis; 2002; 46(3):636-49. PubMed ID: 12243528
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory effects of nitric oxide and gamma interferon on in vitro and in vivo replication of Marek's disease virus.
Xing Z; Schat KA
J Virol; 2000 Apr; 74(8):3605-12. PubMed ID: 10729136
[TBL] [Abstract][Full Text] [Related]
9. Vaccine-induced host responses against very virulent Marek's disease virus infection in the lungs of chickens.
Haq K; Abdul-Careem MF; Shanmuganthan S; Thanthrige-Don N; Read LR; Sharif S
Vaccine; 2010 Aug; 28(34):5565-72. PubMed ID: 20600510
[TBL] [Abstract][Full Text] [Related]
10. Immunity to Marek's disease: where are we now?
Haq K; Schat KA; Sharif S
Dev Comp Immunol; 2013 Nov; 41(3):439-46. PubMed ID: 23588041
[TBL] [Abstract][Full Text] [Related]
11. Induction of innate host responses in the lungs of chickens following infection with a very virulent strain of Marek's disease virus.
Abdul-Careem MF; Haq K; Shanmuganathan S; Read LR; Schat KA; Heidari M; Sharif S
Virology; 2009 Oct; 393(2):250-7. PubMed ID: 19733379
[TBL] [Abstract][Full Text] [Related]
12. Cytokine gene expression patterns associated with immunization against Marek's disease in chickens.
Abdul-Careem MF; Hunter BD; Parvizi P; Haghighi HR; Thanthrige-Don N; Sharif S
Vaccine; 2007 Jan; 25(3):424-32. PubMed ID: 17070626
[TBL] [Abstract][Full Text] [Related]
13. Effects of administration of probiotic lactobacilli on immunity conferred by the herpesvirus of turkeys vaccine against challenge with a very virulent Marek's disease virus in chickens.
Bavananthasivam J; Alizadeh M; Astill J; Alqazlan N; Matsuyama-Kato A; Shojadoost B; Taha-Abdelaziz K; Sharif S
Vaccine; 2021 Apr; 39(17):2424-2433. PubMed ID: 33781599
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of recombinant fowlpox vaccine protection against Marek's disease: its dependence on chicken line and B haplotype.
Lee LF; Bacon LD; Yoshida S; Yanagida N; Zhang HM; Witter RL
Avian Dis; 2004; 48(1):129-37. PubMed ID: 15077806
[TBL] [Abstract][Full Text] [Related]
15. A toll-like receptor 3 ligand enhances protective effects of vaccination against Marek's disease virus and hinders tumor development in chickens.
Parvizi P; Mallick AI; Haq K; Haghighi HR; Orouji S; Thanthrige-Don N; St Paul M; Brisbin JT; Read LR; Behboudi S; Sharif S
Viral Immunol; 2012 Oct; 25(5):394-401. PubMed ID: 22857262
[TBL] [Abstract][Full Text] [Related]
16. Expression of cytokine genes in Marek's disease virus-infected chickens and chicken embryo fibroblast cultures.
Xing Z; Schat KA
Immunology; 2000 May; 100(1):70-6. PubMed ID: 10809961
[TBL] [Abstract][Full Text] [Related]
17. Partial inhibition by turkey herpesvirus of serotype 2 Marek's disease virus plaque formation and in vivo infectivity.
Witter RL; Bacon LD; Calvert JG
Avian Dis; 1994; 38(4):800-9. PubMed ID: 7702514
[TBL] [Abstract][Full Text] [Related]
18. History of the First-Generation Marek's Disease Vaccines: The Science and Little-Known Facts.
Schat KA
Avian Dis; 2016 Dec; 60(4):715-724. PubMed ID: 27902902
[TBL] [Abstract][Full Text] [Related]
19. Effects of T-2 Toxin on Turkey Herpesvirus-Induced Vaccinal Immunity Against Marek's Disease.
Kufuor-Mensah E; Reed WM; Sleight S; Pestka J; Fadly AM; Dunn JR
Avian Dis; 2016 Mar; 60(1):56-62. PubMed ID: 26953944
[TBL] [Abstract][Full Text] [Related]
20. A deletion in the glycoprotein L (gL) gene of U.S. Marek's disease virus (MDV) field strains is insufficient to confer increased pathogenicity to the bacterial artificial chromosome (BAC)-based strain, RB-1B.
Shaikh SA; Katneni UK; Dong H; Gaddamanugu S; Tavlarides-Hontz P; Jarosinski KW; Osterrieder N; Parcells MS
Avian Dis; 2013 Jun; 57(2 Suppl):509-18. PubMed ID: 23901769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
